Carmichael Hill & Associates, Inc. Ark Genomic Revolution ETF (De Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
A detailed history of Carmichael Hill & Associates, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 100 shares of ARKG stock, worth $2,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,155
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
23.4MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$78.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$75.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$60.2 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$60 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$35.7 Million0.02% of portfolio